Patients with ACS due to plaque rupture showed higher plasma levels of MIF than patients with flow limiting stenotic lesions in coronary angiography.

<p>Patients with ACS due to plaque rupture showed higher plasma levels of MIF than patients with flow limiting stenotic lesions in coronary angiography.</p

Results of univariate analysis of covariance (ANCOVA) for MIF and possible confounders in symptomatic CAD.

†<p>Hyperlipidemia was defined as triglycerides ≥175 mg/dl and/or LDL-cholesterol≥100 mg/dl and/or taking any of lipid lowering drugs.</p><p>ASA: aspirin.</p

Association of inflammatory markers IL-6, RANTES, MCP-1 and CRP with MIF levels in the study cohort.

<p>Association of inflammatory markers IL-6, RANTES, MCP-1 and CRP with MIF levels in the study cohort.</p

Baseline characteristics of the studied patients stratified according to median of MIF levels.

*<p>mean value ± standard deviation.</p>†<p>Hyperlipidemia was defined as triglycerides ≥175 mg/dl and/or LDL-cholesterol≥100 mg/dl and/or taking any of lipid lowering drugs.</p><p>ASA: aspirin.</p

Boxplots showing MIF-levels according to acuity of CAD compared with healthy volunteers.

<p>Boxplots showing MIF-levels according to acuity of CAD compared with healthy volunteers.</p

Correlation of the extent of maximum TnI release after PCI in the study cohort.

<p>Correlation of the extent of maximum TnI release after PCI in the study cohort.</p